
GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …

Sanofi chief executive Olivier Brandicourt is reported to be planning hundreds of job cuts across the firm’s base in France, …
Johnson & Johnson has announced a restructuring of its medical devices business unit that could result in up to 3,000 …

Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …

Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …

The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …

Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …

Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …